Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Inflammatory Bowel Diseases

Free Subscription Articles published in JAMA Retrieve available abstracts of 19 articles: HTML format

Single Articles

November 2023
1. SURAN M
   Highlights From Gastroenterology Week: New Crohn Disease Drug, Redefining Liver Disease, and More.
   JAMA. 2023 Nov 2. doi: 10.1001/jama.2023.19140.
   PubMed    
   
   
   September 2023
2. GROS B, Kaplan GG
   Ulcerative Colitis in Adults: A Review.
   JAMA. 2023;330:951-965.
   PubMed     Abstract available
   
   
   March 2023
3. HARRIS E
   Patients With Normal Gut Biopsy Still at Increased Risk of IBD.
   JAMA. 2023;329:875.
   PubMed    
   
   
   
4. ZHANG S, Chen B, Wang B, Chen H, et al
   Effect of Induction Therapy With Olamkicept vs Placebo on Clinical Response in Patients With Active Ulcerative Colitis: A Randomized Clinical Trial.
   JAMA. 2023;329:725-734.
   PubMed     Abstract available
   
   
   April 2022
5. VANDE CASTEELE N
   Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases.
   JAMA. 2022;327:1506.
   PubMed    
   
   
   
6. JAVOR E, Hauser G, Skelin M
   Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases.
   JAMA. 2022;327:1505-1506.
   PubMed    
   
   
   
7. SYVERSEN SW, Jahnsen J, Haavardsholm EA
   Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases-Reply.
   JAMA. 2022;327:1506-1507.
   PubMed    
   
   
   December 2021
8. SYVERSEN SW, Jorgensen KK, Goll GL, Brun MK, et al
   Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
   JAMA. 2021;326:2375-2384.
   PubMed     Abstract available
   
   
   October 2021
9. ABBASI J
   Vaccine-Induced SARS-CoV-2 Antibodies in Inflammatory Diseases.
   JAMA. 2021;326:1365.
   PubMed    
   
   
   September 2021
10. SERKLAND TT, Skrede S, Berg JA
    Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases.
    JAMA. 2021;326:1068-1069.
    PubMed    
    
    
    
11. LE TILLY O, Paintaud G, Ternant D
    Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases.
    JAMA. 2021;326:1069.
    PubMed    
    
    
    
12. PAPAMICHAIL K, Dubinsky MC, Cheifetz AS
    Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases.
    JAMA. 2021;326:1067-1068.
    PubMed    
    
    
    
13. SYVERSEN SW, Bolstad N, Haavardsholm EA
    Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases-Reply.
    JAMA. 2021;326:1069-1070.
    PubMed    
    
    
    July 2021
14. SLOMSKI A
    Filgotinib Induces and Maintains Ulcerative Colitis Remission.
    JAMA. 2021;326:299.
    PubMed    
    
    
    May 2021
15. BAYOUMY AB, de Boer NKH, Mulder CJJ
    Management of Crohn Disease.
    JAMA. 2021;325:1793-1794.
    PubMed    
    
    
    
16. CUSHING K, Higgins PDR
    Management of Crohn Disease-Reply.
    JAMA. 2021;325:1794-1795.
    PubMed    
    
    
    
17. CURTIS JR, Ogdie A, George MD
    Treatment Strategies for Patients With Immune-Mediated Inflammatory Diseases.
    JAMA. 2021;325:1726-1728.
    PubMed    
    
    
    
18. SYVERSEN SW, Goll GL, Jorgensen KK, Sandanger O, et al
    Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
    JAMA. 2021;325:1744-1754.
    PubMed     Abstract available
    
    
    January 2021
19. CUSHING K, Higgins PDR
    Management of Crohn Disease: A Review.
    JAMA. 2021;325:69-80.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.